About Crescent Formulations
Crescent Formulations is a company based in Hyderabad (India) founded in 1997 by Sk Janimiya. It operates as a B2B. The company has 171 employees as of March 31, 2023. Crescent Formulations offers products and services including Antidepressants, Antipsychotics, and Anxiolytics. Crescent Formulations operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Hyderabad, India
- Employees 171 as on 31 Mar, 2023
- Founders Sk Janimiya
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Crescent Formulations Private Limited
- Date of Incorporation 28 Oct, 2010
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$3.61 M (USD)-5.2as on Mar 31, 2023
-
Net Profit
$123.41 K (USD)-29.57as on Mar 31, 2023
-
EBITDA
$408.5 K (USD)-16.81as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
171
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Crescent Formulations
Crescent Formulations offers a comprehensive portfolio of products and services, including Antidepressants, Antipsychotics, and Anxiolytics.
Medications for treating depression and mood disorders
Drugs for managing psychotic conditions and related symptoms
Treatments for anxiety and related mental health issues
Funding Insights of Crescent Formulations
Detailed funding history for Crescent Formulations
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Crescent Formulations
Investment portfolio details for Crescent Formulations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Crescent Formulations
Detailed financials for Crescent Formulations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crescent Formulations Comparisons
Peer comparison for Crescent Formulations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Crescent Formulations
Crescent Formulations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Crescent Formulations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crescent Formulations
Complete news archive for Crescent Formulations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crescent Formulations
Crescent Formulations was founded in 1997.
Crescent Formulations is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Crescent Formulations is 171.
Annual revenue of Crescent Formulations is $3.61M as on Mar 31, 2023.
Crescent Formulations Pvt. Ltd., headquartered in Hyderabad, India, manufactures and supplies affordable pharmaceuticals across therapeutic segments including psychiatry, neurology, orthopedics, and gastroenterology. Established in 1997, it focuses on improving patient well-being by providing quality medicines at reasonable prices. The company emphasizes exceptional service, employee development, and adherence to high standards in production and distribution, serving healthcare providers and patients globally.
Crescent Formulations's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Crescent Formulations offers Antidepressants, Antipsychotics, and Anxiolytics.